Nathan Caffo
Corporate Officer/Principal bij CANDEL THERAPEUTICS, INC.
Actieve functies van Nathan Caffo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CANDEL THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2020 | - |
Loopbaan van Nathan Caffo
Eerdere bekende functies van Nathan Caffo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Corporate Officer/Principal | 01-09-2018 | 01-09-2020 |
Presage Biosciences, Inc.
 Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Algemeen Directeur | 01-04-2009 | 17-07-2018 |
| President | 01-04-2009 | 01-08-2018 |
Opleiding van Nathan Caffo
| The Pennsylvania State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Presage Biosciences, Inc.
Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Health Technology |
- Beurs
- Insiders
- Nathan Caffo
- Ervaring
